Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
Angello,
P19 embryonal carcinoma cells: a model system for studying neural tube induction of skeletal myogenesis.
1997, Pubmed
Angello,
P19 embryonal carcinoma cells: a model system for studying neural tube induction of skeletal myogenesis.
1997,
Pubmed
Edwards,
Induced muscle differentiation in an embryonal carcinoma cell line.
1983,
Pubmed
Jones-Villeneuve,
Retinoic acid-induced neural differentiation of embryonal carcinoma cells.
1983,
Pubmed
Jones-Villeneuve,
Retinoic acid induces embryonal carcinoma cells to differentiate into neurons and glial cells.
1982,
Pubmed
McBurney,
Control of muscle and neuronal differentiation in a cultured embryonal carcinoma cell line.
1982,
Pubmed
Ridgeway,
Myocyte enhancer factor 2C and myogenin up-regulate each other's expression and induce the development of skeletal muscle in P19 cells.
2000,
Pubmed
Ridgeway,
Cloning, tissue distribution, subcellular localization and overexpression of murine histidine-rich Ca2+ binding protein.
1999,
Pubmed
Ridgeway,
Pax3 is essential for skeletal myogenesis and the expression of Six1 and Eya2.
2001,
Pubmed
Ridgeway,
Wnt signaling regulates the function of MyoD and myogenin.
2000,
Pubmed
Rudnicki,
Actin and myosin expression during development of cardiac muscle from cultured embryonal carcinoma cells.
1990,
Pubmed
Rudnicki,
Regulated expression of a transfected human cardiac actin gene during differentiation of multipotential murine embryonal carcinoma cells.
1988,
Pubmed
Skerjanc,
The E box is essential for activity of the cardiac actin promoter in skeletal but not in cardiac muscle.
1994,
Pubmed
Skerjanc,
Cardiac and skeletal muscle development in P19 embryonal carcinoma cells.
1999,
Pubmed
Skerjanc,
Cellular aggregation enhances MyoD-directed skeletal myogenesis in embryonal carcinoma cells.
1994,
Pubmed
Skerjanc,
Myocyte enhancer factor 2C and Nkx2-5 up-regulate each other's expression and initiate cardiomyogenesis in P19 cells.
1998,
Pubmed
,
Xenbase
Smith,
The role of aggregation in embryonal carcinoma cell differentiation.
1987,
Pubmed
Vidricaire,
Expression of the Brachyury gene during mesoderm development in differentiating embryonal carcinoma cell cultures.
1994,
Pubmed
Wilton,
Factors in serum regulate muscle development in P19 cells.
1999,
Pubmed
Wobus,
Cardiomyocyte-like cells differentiated in vitro from embryonic carcinoma cells P19 are characterized by functional expression of adrenoceptors and Ca2+ channels.
1994,
Pubmed
